Evidence-based coverage of weight loss drugs, GLP-1 science, metabolic health, and fat loss strategies. Includes the latest research on Ozempic, Mounjaro, Wegovy, tirzepatide, and semaglutide — reviewed by Dr. Ajit Kumar, MD (Medicine) | MA Psychology.
🦺Medically Written & ReviewedBy Dr. Ajit Kumar, MD (Medicine) — Lifetime Member, Indian Medical Association. About the Author | Editorial Policy A new weight loss drug is generating some of the most striking clinical trial results ever seen in the field of obesity medicine. Survodutide — developed by Boehringer Ingelheim and Zealand Pharma — produced […]
🦺Medically Written & ReviewedBy Dr. Ajit Kumar, MD (Medicine) — Lifetime Member, Indian Medical Association. About the Author | Editorial Policy By now, you’ve heard of Ozempic, Wegovy, and the GLP-1 drug revolution sweeping the world. In 2026 alone, an estimated 13% of adults in the US have used a GLP-1 medication. But what most […]
